Home
Home

Events

Services
 Trade services
 Business Plan
 J1 Visa
 Employment
Advertise
Information about France
 Le Petit Débrouillard

Membership
 Become a Member
 Member Benefits
 Members Directory

Network
 FACC Network
 UCCIFE
 Links

About us

Volunteer

Contact us

 

 

The Life Science Committee
with the support of Swissnex, Baybio, IBMS, and QB3

cordially invites you to join us for a:    

Life Science Breakfast

"Personalized Medicine: Changing the Face of Healthcare?"

 

Thursday, September 29th, 2005
7:30 am - 9:30 am
730, Montgomery Street
San Francisco
CA 94111

At Swissnex

Breakfast will be served

 

Swissnex connects the dots in science, education, art and innovation,
between Switzerland and Western North America


New understandings of disease diagnostics and treatment have fueled predictions of a transition from "sick-care" to more integrative health care systems. Recent withdrawls of blockbuster drugs Vioxx and Tysabri due to safety concerns highlight the dangers of a "one size fits all" drug development model.

Taking the opposite approach, personalized medicine seeks to create differentiated strategies for the prevention and care of disease through the use of 'tailored' medications.  Drawing from the convergence of pharmacogenomics and proteomics, personalized medicine promises to make the drug development process faster, cheaper and more effective while also improving drug safety.

However, this paradigm shift also poses important ethical challenges (such as the need to balance commercial and public health priorities) that will need to be carefully addressed. 

During our breakfast discussion panel, three Bay Area senior executives will share their insights on the meaning and the future of the personalized medicine revolution, to which they have directly contributed as important actors within each of their respective companies.  

 

Time : 7:30am to 9:30am
    7:30 to 8:00 - light breakfast & networking
    8:00 to 8:45 - 10 min talks by each of the 3 panelists
    8:45 to 9:00 - Q&A session with the audience

 

SPEAKERS

Dr. Bob Cohen, Senior Director, Business Development, Genentech

Bob Cohen has worked at Genentech in a variety of capacities since 1994.  Bob is a board certified hematologist/oncologist who completed his training at UCSF before joining the faculty there in 1989.  During this time he did basic research on mechanisms of metastasis and collaborated extensively with Art Levinson.  His clinical specialty was the care of leukemia patients and patients receiving bone marrow transplants.  He is the author of over 30 scientific publications and holds 2 patents.
Bob came to Research upon joining Genentech.  In 1996 he became the project team leader for Herceptin and led that project through Phase III completion and registration.  He also led the Genentech team that co-developed the companion diagnostic HercepTest.  In 1998 he joined Product Development where he managed the Project Management group and the oncology team leaders.  In 2001, he rejoined Research to focus on moving late stage research projects into Development.  In 2003, he left Research to lead a diagnostics effort in Commercial BioOncology.  In 2004, Bob joined Business Development as a senior director in the newly formed Oncology licensing group, where he currently focuses on identifying new in-licensing opportunities.  Bob has a long history of successful work with business development, having played important roles on both the Rituxan and Tarceva in-licensing deals, among others. 
From 1996 until 2002, Bob led a company-wide cross-functional team to provide strategic direction for Genentech’s burgeoning oncology business.  His personal mission is to help achieve the best possible outcomes for cancer patients.  In addition to his work at Genentech, Bob has served on a number of external scientific advisory boards, including several NIH committees and the scientific advisory board of ABC2, a brain cancer research and advocacy organization.
He is an avid skier, hiker, roller-blader, and is known in some Genentech circles for his love of arcane trivia.
 

Dr. Thane Kreiner, Senior Vice President, Corporate Affairs for Affymetrix, Inc.

Thane is Vice President, Corporate Affairs for Affymetrix, Inc., a leading manufacturer of DNA microarray technology. Prior to his current position, Dr. Kreiner held various other management positions at Affymetrix from 1994 to 2000, including Vice President, Sales and Marketing; and Vice President, Marketing and Strategic Planning during the development of the Company's technology and scale-up of its commercial operations. He joined the Company full-time in April, 1994 while completing his MBA at Stanford University Graduate School of Business.
Dr. Kreiner received his Ph.D. in Neurosciences from Stanford University in 1988.
His undergraduate at the University of Texas, Austin led to a B.S. in Chemistry in 1983.
 

Martin L. Verhoef, President of Ciphergen Biosystems Division and an Executive Vice President of Ciphergen Biosystems, Inc.

Martin L. Verhoef, is President of Ciphergen’s Biosystems Division and an Executive Vice President of Ciphergen Biosystems, Inc. Prior to joining Ciphergen, he was with Hewlett-Packard/Agilent Technologies, Inc. from 1990 to 2000. He was Marketing Manager, Bioscience Products from March 1999 to April 2000, System Program Manager, Bioscience Products from September 1997 to February 1999 and Marketing Section Manager, Bioscience Products from June 1996 to August 1997. Prior to that he was Product Marketing Manager, Capillary Electrophoresis and Liquid Chromatography from 1990 to 1996 at Hewlett-Packard GmbH, in Waldbronn, Germany. From 1985 to 1990 he was Product Manager, Process Chromatography at Pharmacia LKB Biotechnology AB in Sweden. He received a BS (Hons) degree in Medical Microbiology and Biochemistry from the Van t Hoff Institute in Rotterdam, the Netherlands.

MODERATOR

Dr. Heather Koshinsky, CEO, President and co-founder, Investigen, Inc.

Dr. Heather Koshinsky, CEO, President and co-founder. Dr. Koshinsky is a microbial geneticist who previously worked at the Plant Gene Expression Center and at the University of Saskatchewan.
She supervised microbiological/molecular biological research projects involving yeast and bacterial genetics and food safety. Dr. Koshinsky was also an assistant professor with University of Saskatchewan. Dr. Koshinsky obtained a B.Sc. in Biology and a Ph.D. in Applied Microbiology from University of Saskatchewan, and a Certificate of Business Administration from University of California, Berkeley Extension.

To register
 


REGISTRATION.

French American Chamber of Commerce
info@faccsf.com

Tel: 415 442 4717 / Fax: 415 442 4621
703 Market Street, Suite 450 - San Francisco, CA 94103
 

Registration price valid until 5-days prior to the event date


Registration is closed!

$30 At the Door

 

Cancellations must be made 5-days prior to the event date
Any cancellation within a 5-day period of the scheduled date will not be refund
Name of guest will be kept at the door

 

 

Or pay using the order form

 

French-American Chamber of Commerce - Life Science Breakfast:

Thursday, September 29th 2005, 7:30 am - 9:30 am
 

I wish to reserve ___ tickets at $20 for FACCSF members and affiliated only

                        ___ tickets at $25 for non members

 

Name _________________________________________________________________________

Company_______________________________________________________________________

Address________________________________________________________________________

City________________________________________State___________Zip__________________

Email address___________________________________________________________________

Phone ______________________________________Fax________________________________

Visa/MC Number_________________________________________________________________

Exp. Date___________________________________ Signature____________________________

 

Please, fax this coupon to:

 

French-American Chamber of Commerce

703 Market Street, Suite 450, San Francisco, CA 94103

Tel: 415 442 4717 / Fax 415 442 4621